Impact of a non-medical switch from tocilizumab to upadacitinib in a cohort of patients with rheumatoid arthritis in routine clinical practice

被引：0
|
作者：
White, Douglas [1 ]
Poppelwell, David [2 ]
机构：
[1] Te Whatu Ora Waikato, Waikato Hosp, Rheumatol Clin, Hamilton, New Zealand
[2] AbbVie Ltd, Med Affairs, Auckland, New Zealand
来源：
NEW ZEALAND MEDICAL JOURNAL | 2023年 / 136卷 / 1581期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 78
页数：5
相关论文
共 50 条
  • [1] IMPACT OF A NON-MEDICAL SWITCH FROM TOCILIZUMAB TO UPADACITINIB IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ROUTINE CLINICAL PRACTICE
    White, Douglas
    Poppelwell, David
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 34 - 34
  • [2] Effectiveness of intravenous tocilizumab in routine clinical practice in a cohort of Costa Rican patients with rheumatoid arthritis
    Cordero-Alfaro, Mauricio
    Leon-Cespedes, Carlos
    Ramos-Esquivel, Allan
    REUMATOLOGIA CLINICA, 2021, 17 (06): : 329 - 334
  • [3] NON-MEDICAL SWITCHING FROM TOCILIZUMAB TO SARILUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY
    Den Broeder, N.
    Den Broeder, A.
    Verhoef, L. M.
    Van den Hoogen, F.
    Van der Maas, A.
    Van den Bemt, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 593 - 594
  • [4] Non-Medical Switching from Tocilizumab to Sarilumab in Rheumatoid Arthritis Patients with Low Disease Activity, an Observational Study
    den Broeder, Nathan
    den Broeder, Alfons A. A.
    Verhoef, Lise M. M.
    van den Hoogen, Frank H. J.
    van Der Maas, Aatke
    van den Bemt, Bart J. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (04) : 810 - 814
  • [5] Analysis of effectiveness, safety and optimization of tocilizumab in a cohort of patients with rheumatoid arthritis in clinical practice
    Mena-Vazquez, Natalia
    Manrique-Arija, Sara
    Rojas-Gimenez, Marta
    Urena-Garnica, Inmaculada
    Jimenez-Nunez, Francisco G.
    Fernandez-Nebro, Antonio
    REUMATOLOGIA CLINICA, 2019, 15 (01): : 21 - 26
  • [6] EFFECTIVENESS OF TOCILIZUMAB IN MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE
    Magallares, B.
    Quesada-Masachs, E.
    Hernandez, M.
    Lisbona, M.
    Moya, P.
    Moreno, M.
    Torrente-Segarra, V.
    Reina, D.
    Narvaez, J.
    Marsal, S.
    Sanmarti, R.
    Calvet, J.
    Maymo, J.
    Diaz-Torne, C.
    Gomez, A.
    Corominas, H.
    Nolla, J.
    Rodriguez de la Serna, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1042 - 1042
  • [7] Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
    Pers, Yves-Marie
    Fortunet, Clementine
    Constant, Elodie
    Lambert, Joseph
    Godfrin-Valnet, Marie
    De Jong, Audrey
    Mercier, Gregoire
    Prades, Beatrice Pallot
    Wendling, Daniel
    Gaudin, Philippe
    Jorgensen, Christian
    Marotte, Hubert
    Maillefert, Jean-Francis
    RHEUMATOLOGY, 2014, 53 (01) : 76 - 84
  • [8] Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
    Pappas, Dimitrios A.
    Etzel, Carol J.
    Zlotnick, Steve
    Best, Jennie
    Blachley, Taylor
    Kremer, Joel M.
    RHEUMATOLOGY AND THERAPY, 2019, 6 (03) : 421 - 433
  • [9] Patterns of Prednisone Use in US Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine Clinical Practice
    Pappas, Dimitrios A.
    Etzel, Carol J.
    Best, Jennie
    Zlotnick, Steve
    Blachley, Taylor
    Persuitte, Gioia
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
    Dimitrios A. Pappas
    Carol J. Etzel
    Steve Zlotnick
    Jennie Best
    Taylor Blachley
    Joel M. Kremer
    Rheumatology and Therapy, 2019, 6 : 421 - 433
12345